Experienced in Subacute Combined Degeneration

Laurent D. Kremer

Montpellier, FR 
Experienced in Subacute Combined Degeneration
Montpellier, FR 
OverviewLocationsClinical Research

Overview

Laurent Kremer practices in Montpellier, France. Mr. Kremer is rated as an Experienced expert by MediFind in the treatment of Subacute Combined Degeneration. His top areas of expertise are Neuromyelitis Optica, Transverse Myelitis, Optic Neuritis, and Multiple Sclerosis (MS).

His clinical research consists of co-authoring 248 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Subacute Combined Degeneration.

Gender
Male

Locations

Montpellier, France
Other Locations
CHU de Strasbourg
Strasbourg, France
Paris, France
1 Avenue De Molière 67200 Strasbourg, Moliere, 67200, France
Caen, France
Lyon, France
34965, France
Marseille, France
UMR1173, Université De Versailles St. Quentin, Montigny-sur-loing, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Study of the Seroprevalence of SARS-CoV-2 in Hospital Staff in Strasbourg University Hospital, Strasbourg, France
Study of the Seroprevalence of SARS-CoV-2 in Hospital Staff in Strasbourg University Hospital, Strasbourg, France
Enrollment Status: Completed
Publish Date: January 20, 2026
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis
Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis
Enrollment Status: Terminated
Publish Date: July 27, 2020
Intervention Type: Radiation
Study Phase: Phase 4
View 1 Less Clinical Trial

248 Total Publications

A bioluminescence-based chemical screen identifies a bactericidal naphthalene scaffold targeting MmpL3 in Mycobacterium abscessus.
A bioluminescence-based chemical screen identifies a bactericidal naphthalene scaffold targeting MmpL3 in Mycobacterium abscessus.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kremer's expertise for a condition
ConditionClose
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile